Company: TAK
Filing Date: 2025-10-30
Form Type: 6-K
Source: 0001395064-25-000152
Chunk: 1

Company: TAKEDA PHARMACEUTICAL CO LTD
Filing Date: 2025-10-30
Form: 6-K
Chunk 1
---
5 (IFRS, Consolidated)

October 30, 2025

| Takeda Pharmaceutical Company Limited |     |                                   |     | Stock exchange listings:    |     | Tokyo, Nagoya, Sapporo, Fukuoka     |
| TSE Code:                             |     |                              4502 |     | URL: https://www.takeda.com |     |                                     |
| Representative:                       |     | Christophe Weber, President & CEO |     |                             |     |                                     |
| Contact:                              |     |              Christopher O'Reilly |     | Telephone: +81-3-3278-2111  |     | Email: takeda.ir.contact@takeda.com |
|                                       |     | Global Head of IR, Global Finance |     |                             |     |                                     |

| Scheduled date of semi-annual securities report submission: October 30, 2025 
 Scheduled date of dividend payment commencement: December 1, 2025            |
|:-----------------------------------------------------------------------------|
| Supplementary materials for the financial statements: Yes                    |
| Presentation to explain the financial statements: Yes                        |

(Million JPY, rounded to the nearest million)

(1) Consolidated Operating Results (year to date)

|                                           |     |                            |           |     |    |       |     |                       |          |     |    |       |   |     |                   |         |     |    |        |     |                  |         |     |    |        | -Percentage figures represent changes over the same period of the previous year |
|                                           |     | Revenue                    |           |     |    |       |     | Operating profit      |          |     |    |       |   |     | Profit before tax |         |     |    |        |     | Net profit       
 for the period   |         |     |    |        |                                                                                 |
|                                           |     | -Million JPY               |           |     | -% |       |     | -Million JPY          |          |     | -% |       |   |     | -Million JPY      |         |     | -% |        |     | -Million JPY     |         |     | -% |        |                                                                                 |
| Six-month Period Ended September 30, 2025 |     |                            | 2,219,481 |     |    |  -6.9 |     |                       |  253,561 |